Introduction
The initial report (Bulbrook, Greenwood and Hayward, 1960) showing a statistical link between the urinary excretion of 17-hydroxycorticosteroids (17-OHCS) and 1 1-deoxy-17-ketosteroids (11-DOKS) and the response of patients with breast cancer to endocrine ablation has been followed by several similar observations in other centres. The current position regarding steroid excretion in patients with breast cancer has been amply covered (Bulbrook, 1965; Hayward and Bulbrook, 1968; Bulbrook, 1969) . -In summary, the findings were that those women with advanced cancer of the breast who had a relatively high ratio of 11-DOKS to 17-OHCS in the urine (as expressed by the discriminant function 80-80 (17-OHCS in mg.) + aetiocholanolone in usg.) had a better response to endocrine ablation, particularly hypophysectomy.
The predictive value of this "discriminant function" is strengthened by inclusion of the free period and menopausal status (Atkins et al., 1964) . The results from other centres have shown that the ability to "discriminate" between those who would respond and those who would not varies considerably, and unanimity in the field has yet to be achieved. The results of the Portsmouth group (Miller, Durant, Jacobs, and Allison, 1967; Miller and Durant, 1968) , who have collaborated closely with Bulbrook and his colleagues on methodological problems (Thomas, Bulbrook, Durant, Miller, and Ross, 1969) agree closely. On the other hand, two other centres were unable to show satisfactory discrimination between the responders and non-responders (Ahlquist, Jackson, and Stewart, 1968; Wade, Davis, Tweedie, Clarke, and Haggart, 1969) , and indeed Thomas, Bulbrook, and Hayward (1967) did not obtain quite such good discrimination in their second and somewhat larger series studied. Thus the value of these urinary steroid analyses has remained uncertain. Discrimination apart, Bulbrook, Hayward, and their colleagues (Hayward and Bulbrook, 1968) have also shown that about half the patients with primary breast cancer have abnormally low excretion of aetiocholanolone and that the survival rates, up to eight years after mastectomy, are greater in those patients with normal values. This was the first observation that abnormal values of urinary steroids may be present at the stage of primary disease and that they may have an influence on prognosis.
The present study was undertaken to examine the patterns of steroid excretion in women with benign and malignant diseases of the breast in South Wales.
Patients and Methods
Estimations of urinary steroids were made in a total of 177 women. Of these 21 were patients without known breast disease or malignant disease of any kind who had been admitted to hospital for elective general surgical operations; 63 had benign disease of the breast, proved by excision biopsy of a palpable lump, 30 had primary breast cancer, subsequently treated by mastectomy, and 63 were patients with advanced breast cancer, subsequently treated by hormone administration or ablation of endocrine glands. Twenty-one patients in this advanced group had disease limited to the breasts, chest Thomas and Bulbrook (1964 Few (1961) . The technique used for the determination of the 11-DOKS and androsterone, aetiocholanolone, and dehydroepiandrosterone was essentially similar to that of Thomas and Bulbrook (1964) as modified by Thomas (1965) . Since, however, various modifications in this method were introduced, the complete experimental approach used is now given for the sake of clarity.
Urine Collection.-Two consecutive 24-hour collections were made for each patient. Since the levels of urinary steroids vary considerably in response to stress, the conditions under which the collections were made were standardized as carefully as possible. All patients were in hospital (most were admitted to the same ward) and the collections made before treatment was carried out. The specimens were kept cool during collection and combined on completion of the 48-hour period. A portion was then stored in the frozen state without preservative until analysed.
Extraction.-Fifty millilitres of the combined specimen was brought to pH 6.5, using N HISOt or N NaOH, and placed in a 250-ml. separating funnel. Hydrolysis and Solvolysis.-f3-Glucuronidase powder, assayed by the method of Talalav, Fishman, and Huggins (1946) , was homogenized in acetate buffer (0-5 M, pH 4-0) and centrifuged to give a clear supernatant. This supernatant was diluted with acetate buffer to give a final concentration of about 2,000 units/ml. Then 5 ml. of this solution was added to the dry steroid extract and the mixture incubated for 16 hours at 40'C. After the hydrolysis, 16-4 ml. of a 27 00, (w/v) NaCl solution was added to the incubation mixture and the pH reduced to 1.0 with 4N H2SOs. Extraction of free steroids and conjugates was effected by shaking twice with 20-ml. volumes of ethyl acetate. Pooled extracts were then incubated for four hours at 50'C. (Burstein and Lieberman, 1958) . On reduction of the volume to about 10 ml., 30 ml of n-heptane was added and the mixture shaken successively three times with 5 ml. of 50°X, Na2S2O(; in N NaOH (w/v) and twice with 2.5 ml. of distilled water. As also found by Thomas and Bulbrook (1964) this procedure effectively removed most of the urinary pigments, and on evaporating the solution to dryness the residue was transferred to a B14 test-tube with three more 4-ml. volumes of ethanol. Finally, this solution was taken to dryness and the residue concentrated in the bottom of the tube.
Paper Chromatography.-Strips of Whatman No. 4 chromatography paper were prepared according to the design of Thomas and Bulbrook (1964) . The extract was applied to the origin and the bottom half of the chromatogram dipped in a 30%6 v/v solution of propane-1 .2-diol in methanol. This solution was then allowed to "run up" to the origin by capillary action, and when the process was complete the chromatogram was removed, shaken, and allowed to dry for 10 minutes. Chromatography was then carried out exactly as described by the above authors and the heptane eluate (fraction, 0-05-3.5 ml.) evaporated to dryness in a B14 test-tube.
Radioactivity Measurement and Derivative Formation.-The dried residue was dissolved in 1 ml. of ethanol containing 10 Mg. of 5a-androstane-3a,17,3-diol, and 0-1 ml. of this solution was removed and placed in a liquid scintillation phial. On evaporation of the solvent the residue in the phial was dissolved in 10 ml. of toluene containing 3 g./l. PPO minutes, and redissolved in a mixture of n-hexane (200 Al.), hexamethyldisilazane (250 A.l.), and trimethylchlorosilane (100 1LL). On standing overnight a portion of the solution was injected without further treatment on to the column of the gas chromatography. This procedure was found to give quantitative trimethylsilyl ether formation.
Gas-Liquid Chromatography.-Initially of 275-cm. glass column (4 mm. internal diameter) was packed with GasChrom Q (100-120 mesh) supporting 0.35°O SE-30 and 0-60% XE-60 prepared as a "hybrid" column by successively evaporating solutions of each phase down on to the support. This type of column, however, did not give adequate separation of androsterone and aetiocholanolone in our hands, and consequently the last 60 cm. (detector end) was replaced by GasChrom Q supporting a 1% NPGS phase. The column was conditioned at 210 C. for 48 hours and operated isothermally at 190'C. with a N2 flow rate of 60 ml./min. This column was found to give excellent separations of all the steroids encountered, including the contaminant described by Thomas (1965) , and was thence used throughout the study.
Results
Preliminary statistical analysis of the urinary steroid levels showed that the absolute values of each steroid were not normally distributed around the mean, but had a definitely skew distribution. A unimodal and symmetrical distribution was, however, obtained by conversion of the values to logarithms to the base 10, and logarithmic values were therefore used in all subsequent analyses.
Comparison of the age distribution within each group (Table I) showed an obvious difference. The mean ages of the primary and advanced groups were similar. Those of the normal and benign groups, however, were lower, differing from the primary and advanced by seven and fifteen years, respectively.
Cj,-steroid Analysis
Comparison of the logarithmic values of aetiocholanolone showed that though there was no difference between the mean values of the normal, benign, and primary groups (Table II) there was a difference when the advanced group as a whole was compared with each of the other groups. This difference reached statistical significance in the case of the benign and primary groups (P<0.1), and the fact that it did not reach significance when the advanced group was compared with the normal group (P<0-2) probably reflects the small size of the sample. Similarly, when the mean logarithmic values for androsterone in each group were compared there was no difference between the normal, benign, and More detailed statistical analysis of the urinary C,-steroid excretion values were then undertaken. Since there was an age difference between the groups studied, the logarithmic values of aetiocholanolone were related to age for each patient. The values for normal patients and those with benign disease were found to increase during early adult life and then decrease with advancing age. The best calculated curve was a parabola which gave a maximum aetiocholanolone excretion between 38 and 40 years of age in each of the two groups (Fig. 1 ). Since there were few patients with breast cancer below the age of 38, the further analysis was limited to patients over that age when a linear regression fitted the association between the logarithmic values of aetiocholanolone and age.
Analysis of covariance showed that the regression coefficients for the normal, benign, primary, and advanced groups were similar (Table III) and that a common regression coefficient could be used. Following from this, regression lines were drawn which showed that patients with advanced disease were different from the others and had significantly lower logarithmic levels of aetiocholanolone regardless of age (Fig. 2) . To examine this difference further, the patients were considered according to the distribution of their disease, and regression lines were drawn separately for those with advanced local and those with advanced general disease (Fig.  3) . They confirmed that the group with advanced localized disease was distinct from all others and that such patients have significantly lower levels of aetiocholanolone.
Calculations of the pooled standard deviation were determined for patients aged 50 and used to test the significance of difference between pairs of expected mean values. These studies confirmed that the group with advanced localized disease was distinct from all others and that such patients have significantly lower levels of aetiocholanolone when adjusted for age. When the difference in logarithmic values between the advanced localized disease and each of the other groups was converted back to a primary number, it was about 500 ttg., or 45 % of the mean value of each of the other groups.
The normal and primary groups behaved in a similar manner whereas the benign group had levels of aetiocholanolone little different from those of the patients in the advanced group. The differences between these four groups did not, however, reach statistical significance.
A similar analysis of the androsterone results was undertaken. There was a similar relationship between logarithmic values of androsterone and age, the results again fitting a parabolic curve reaching a peak at about 40 years of age. As with aetiocholanolone, however, the age of 38 was used for the further analysis. Analysis of covariance showed again that a common coefficient could be used, and the drawn regression lines (Fig. 4) with advanced localized breast cancer again, regardless of age, had the lowest levels of androsterone. The difference was not as great as shown with aetiocholanolone.
17-OHCS Analysis
The mean values of 17-OHCS excretion did not vary between the different groups (Table II) . Furthermore, detailed analysis did not show the parabolic relationship between urinary excretion and age, and a regression analysis failed to reveal any differences (Fig. 5 ).
Discussion
The results we describe support the view of others (Bulbrook et al., 1960; Bulbrook, 1965; Juret, 1968; Wilson and Moore, 1968 ) that steroid excretion in many patients with breast cancer differs from that of the normal population. Equally clearly our conclusions regarding this difference throughout the spectrum of breast disease do not entirely coincide with some previous opinions. The figures show that in the population studied by the methodology used in our laboratory 11-DOKS excretion in normal women and in those with benign breast disease or primary breast cancer are virtually indistinguishable. Abnormal levels of 11-DOKS were found only in patients with advanced cancer of the breast and, so far as our data are concerned, no abnormality of steroid excretion was present in patients with primary cancer of the breast. This was in contrast to earlier observations of Hayward and Bulbrook (1968) .
It was also noted that patients with advanced localized disease predominantly show abnormal steroid excretion, an interesting observation in the light of experience that such patients tcrn to respond badly to endocrine ablation. Furthermore. in a controlled randomized trial to de ermine whethe; early endocrine ablation (90Y implant of the pituitary) carried any advantage over delaying it until other simpler forms of treatment have been tried, we found that patients with localized disease again behaved differently from those in whom widespread dissemination had occurred (Stewart et al., 1969) .
Rationalization of these observations in physiological terms is somewhat difficult. Perhaps the discriminating power of the Bulbrook discriminant function is in some way related to the distribution of the disease. Noteworthy are the observations of Bulbrook (1969) that the original results from the application of the discriminant function to patients with primary breast cancer (Hayward and Bulbrook, 1968) required some modification when larger numbers were studied, though they could still state that assays of li-DOKS and 17-OHCS are of value in identifying patients with primary breast cancer at high risk of recurrence (Bulbrook, 1969) . Our results would therefore indicate that an abnormal level of urinary steroids is confined to patients with advanced cancer of the breast, and would appear to be a result of rather than a precedent to spread of the disease. Interestingly, however, recent work on the extent of metabolism by breast tissue of steroids found in the plasma Griffiths, Jones, Cameron, Gleave, and Forrest, 1970) would not support the view that such metabolism contributes significantly to the pattern of 11-DOKS excretion. Obviously a great deal has still to be learnt about the endocrinology of breast cancer.
